As of May 18
| +0.20 / +0.20%|
The 15 analysts offering 12-month price forecasts for ResMed Inc have a median target of 94.61, with a high estimate of 109.08 and a low estimate of 75.00. The median estimate represents a -6.91% decrease from the last price of 101.63.
The current consensus among 19 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.